Citrinal B, natural 11 beta-hydroxysteroid dehydrogennase type 1 inhibitor identified from structure-based virtual screening

被引:4
作者
Cao, Jie [1 ]
Gao, Limin [1 ]
Chen, Yizhan [2 ]
Sun, Weiguang [3 ]
Wang, Fuqian [4 ]
Li, Hua [3 ]
Zhang, Yonghui [3 ]
机构
[1] Huazhong Univ Sci & Technol, Tonsil Med Coll, Union Hosp, Wuhan 430030, Hubei, Peoples R China
[2] Huazhong Univ Sci & Technol, Tonsil Med Coll, Tongji Hosp, Wuhan 430030, Hubei, Peoples R China
[3] Huazhong Univ Sci & Technol, Tonsil Med Coll, Hubei Key Lab Nat Med Chem & Resource Evaluat, Wuhan 430030, Hubei, Peoples R China
[4] Wuhan First Hosp, Dept Pharm, Wuhan 430022, Hubei, Peoples R China
基金
中国国家自然科学基金;
关键词
11; beta-HSD1; inhibitor; Citrinal B; Natural product; Virtual screening; ADIPOSE-TISSUE; 11-BETA-HSD1; EXPRESSION; METABOLISM; OBESITY;
D O I
10.1016/j.fitote.2017.09.018
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Citrinal B, a tricyclic compound from endophytic fungus Colletotrichum capsici in our previous studies, exhibited significant inhibitory activity against 11 beta-hydroxysteroid dehydrogenase type 1 (11 beta-HSD1) in vitro and showed strong binding affinity to 11 beta-HSD1. Moreover, citrinal B treatments decreased the lipid droplet accumulation associate with the inhibition of 11 beta-HSD1 expression in differentiate induced 3T3-L1 preadipocytes. Furthermore, the molecular docking demonstrated that citrinal B coordinated in the active site of 11 beta-HSD1 is essential for the ability of diminishing the enzyme activity.
引用
收藏
页码:29 / 34
页数:6
相关论文
共 48 条
[41]   Structure-Based Pharmacophore Modeling, Virtual Screening, Molecular Docking, ADMET, and Molecular Dynamics (MD) Simulation of Potential Inhibitors of PD-L1 from the Library of Marine Natural Products [J].
Luo, Lianxiang ;
Zhong, Ai ;
Wang, Qu ;
Zheng, Tongyu .
MARINE DRUGS, 2022, 20 (01)
[42]   Integrated use of ligand and structure-based virtual screening, molecular dynamics, free energy calculation and ADME prediction for the identification of potential PTP1B inhibitors [J].
Bharti Devi ;
Sumukh Satyanarayana Vasishta ;
Bhanuranjan Das ;
Anurag T. K. Baidya ;
Rahul Salmon Rampa ;
Manoj Kumar Mahapatra ;
Rajnish Kumar .
Molecular Diversity, 2024, 28 :649-669
[43]   Structure-based Virtual Screening from Natural Products as Inhibitors of SARS-CoV-2 Spike Protein and ACE2 Receptor Binding and their Biological Evaluation In vitro [J].
Delgado-Maldonado, Timoteo ;
Donaldo Gonzalez-Morales, Luis ;
Juarez-Saldivar, Alfredo ;
Lara-Ramirez, Edgar E. ;
Rojas-Verde, Guadalupe ;
Moreno-Rodriguez, Adriana ;
Bandyopadhyay, Debasish ;
Rivera, Gildardo .
MEDICINAL CHEMISTRY, 2024, 20 (05) :546-553
[44]   Identification of Potent Chloride Intracellular Channel Protein 1 Inhibitors from Traditional Chinese Medicine through Structure-Based Virtual Screening and Molecular Dynamics Analysis [J].
Wang, Wei ;
Wan, Minghui ;
Liao, Dongjiang ;
Peng, Guilin ;
Xu, Xin ;
Yin, Weiqiang ;
Guo, Guixin ;
Jiang, Funeng ;
Zhong, Weide ;
He, Jianxing .
BIOMED RESEARCH INTERNATIONAL, 2017, 2017
[45]   Discovery of Highly Potent Benzimidazole Derivatives as Indoleamine 2,3-Dioxygenase-1 (IDO1) Inhibitors: From Structure-Based Virtual Screening to in Vivo Pharmacodynamic Activity [J].
Serafini, Marta ;
Torre, Enza ;
Aprile, Silvio ;
Del Grosso, Erika ;
Gesu, Alessandro ;
Griglio, Alessia ;
Colombo, Giorgia ;
Travelli, Cristina ;
Paiella, Salvatore ;
Adamo, Annalisa ;
Orecchini, Elena ;
Coletti, Alice ;
Pallotta, Maria Teresa ;
Ugel, Stefano ;
Massarotti, Alberto ;
Pirali, Tracey ;
Fallarini, Silvia .
JOURNAL OF MEDICINAL CHEMISTRY, 2020, 63 (06) :3047-3065
[46]   Discovery, design and synthesis of 6H-anthra[1,9-cd]isoxazol-6-one scaffold as G9a inhibitor through a combination of shape-based virtual screening and structure-based molecular modification [J].
Chen, Wei-Lin ;
Wang, Zhi-Hui ;
Feng, Tao-Tao ;
Li, Dong-Dong ;
Wang, Chu-Hui ;
Xu, Xiao-Li ;
Zhang, Xiao-Jin ;
You, Qi-Dong ;
Guo, Xiao-Ke .
BIOORGANIC & MEDICINAL CHEMISTRY, 2016, 24 (22) :6102-6108
[47]   Computational repurposing approach for targeting the critical spike mutations in B.1.617.2 (delta), AY.1 (delta plus) and C.37 (lambda) SARS-CoV-2 variants using exhaustive structure-based virtual screening, molecular dynamic simulations and MM-PBSA methods [J].
Ebrahimi, Maryam ;
Karami, Leila ;
Alijanianzadeh, Mahdi .
COMPUTERS IN BIOLOGY AND MEDICINE, 2022, 147
[48]   Structure-based discovery of 1-(3-fluoro-5-(5-(3-(methylsulfonyl) phenyl)-1H-pyrazolo[3,4-b]pyridin-3-yl)phenyl)-3-(pyrimidin-5-yl)urea as a potent and selective nanomolar type-II PLK4 inhibitor [J].
Sun, Yin ;
Wang, Lin ;
Sun, Yu ;
Wang, Jingkai ;
Xue, Yanli ;
Wu, Tianxiao ;
Yin, Wenbo ;
Qin, Qiaohua ;
Sun, Yixiang ;
Wang, Hanxun ;
Gao, Yinli ;
Yang, Huali ;
Zhao, Dongmei ;
Cheng, Maosheng .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2022, 243